Extracorporeal photopheresis: an effective treatment for pulmonary graft versus host disease

V. Taylor (London, United Kingdom), M. Klammer (London, United Kingdom), R. Aul (London, United Kingdom)

Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Taylor (London, United Kingdom), M. Klammer (London, United Kingdom), R. Aul (London, United Kingdom). Extracorporeal photopheresis: an effective treatment for pulmonary graft versus host disease. 3488

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Extracorporeal therapies in sepsis: from toraymyxin to CPFA
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Extracorporeal photopheresis after lung transplantation: a 10-year single-centre experience
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Extracorporeal membrane oxygenation for the treatment of acute exacerbation of interstitial lung diseases
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017



Comparison of extracorporeal photopheresis efficacy in treated versus non-treated patients with refractory BOS.
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Extracorporeal life support in lung failure and lung transplant bridging: when and how
Source: Virtual Congress 2020 – Extracorporeal life support in lung failure and lung transplant bridging: when and how
Year: 2020

The use of extracorporeal membrane oxygenation (ECMO) in severe delayed graft dysfunction after lung transplant
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014

Extracorporeal photopheresis in lung transplant:The initial experience in our hospital
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014


“Treat-to-target” in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation
Source: Eur Respir Rev 2011; 20: 297-300
Year: 2011


Lung transplantation for pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 247-255
Year: 2012


Advanced therapies for life-threatening PE: low-dose systemic thrombolysis, catheter-directed thrombolysis and extracorporeal membrane oxygenation (ECMO)
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018


Extracorporeal life support (ECLS) as a bridge to lung transplantation (LTx)
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


Extracorporeal membrane oxygenation for adults with active malignancy: Is there difference to clinical outcome between hematologic and oncologic?
Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Year: 2020

Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism
Source: Eur Respir J, 53 (4) 1801773; 10.1183/13993003.01773-2018
Year: 2019



Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Extracorporeal photoapheresis in the treatment of chronic lung rejection: preliminary clinical and immunological results on a small cohort of lung recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008

Case presentation: Extracorporeal CO2 removal and veno venous ECMO as bridge to transplantation in refractory hypercapnic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


The influence of extracorporeal photopheresis on NFκB signaling and cytokine expression in lung transplant patients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016



Extracorporeal lung support (ECLS) as a bridge to lung transplant: the Pavia experience
Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems
Year: 2009